Nuvectis Pharma, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Nuvectis Pharma, Inc. has issued its proxy statement for the 2026 Annual Meeting of Stockholders to be held virtually on June 11, 2026.
NASDAQ
Nuvectis Pharma's upcoming annual meeting on June 13, 2024, will include voting on the election of directors and ratification of the company's accounting firm.
NASDAQ
Nuvectis Pharma will hold its annual stockholders meeting virtually on June 12, 2025, to elect a director and ratify the appointment of its accounting firm.
NASDAQ
Nuvectis Pharma's upcoming annual meeting on June 13, 2024, will include voting on the election of directors and ratification of the company's accounting firm.
NASDAQ
Nuvectis Pharma will hold its Annual Meeting of Stockholders virtually on June 13, 2024, to elect directors and ratify the appointment of its independent auditor.